Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BKNG vs GSK✓SelectedUSD · GSKBKNG vs GSK performance historyLatest closeAs of-1.64%11/20
Stock and ETF performance explorer

BKNG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+645.8%
GSK return
+142.9%
Excess return
+503.0%
Maximum drawdown
-99.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-0.1%-1.5%-1.6%
7D-9.2%-5.3%-3.9%-7.2%
30D-8.5%-3.7%-4.8%-7.1%
3M-30.8%-7.3%-23.5%-28.7%
6M-7.2%-4.2%-3.0%-5.8%
YTD-31.9%+0.9%-32.7%-32.8%
1Y-20.2%+7.3%-27.5%-23.2%
3Y+17.4%+52.7%-35.3%-5.2%
5Y+58.5%+40.1%+18.4%+30.8%
10Y+146.0%+98.7%+47.3%+73.3%
All+645.8%+142.9%+503.0%+392.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling